ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 639366 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 639366; 2) Community: the network communities that were significantly associated with the response to NSC 639366; 3) Molecule: the relationships between components within communities and NSC 639366; 4) MDR: the compounds that were significantly associated with the NSC 639366.

NSC Compound Enrichment Correlation
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0490935610249067 0.54159657
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0490935610249067 0.24904928
NSC 40618 Cyclohexanone, 2,6-dibenzylidene- (8CI) 0.0490935610249067 0.51095068
NSC 45236 Null 0.0490935610249067 0.27860586
NSC 55236 Null 0.0490935610249067 0.22027646
NSC 603071 Aminocamptothecin 0.0490935610249067 0.41578535
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0490935610249067 0.49738386
NSC 604976 Verrucarin A, 7'-deoxo-2'-deoxy-2',3'-epoxy-8',9',10',11'- tetrahydro-4',8-dihydroxy-7'-(1-hydroxyethyl)- 0.0490935610249067 0.24220848
NSC 606497 Camptothecin Derivative 0.0490935610249067 0.43461703
NSC 617394 Null 0.0490935610249067 0.34917925
Total:147  Current:140    [First] [Prev] [Next] [Last]